Dr Hervé Broly | Vice President Biotech Process Sciences
Merck Serono

Starting with an Engineering degree coupled with a doctorate in Physiology, Hervé Broly developed the manufacture of monoclonal antibodies for diagnostic reagent and therapeutical use at the Regional Blood Transfusion Center of Lille (France) from 1982 to 1991 and then at a subsidiary of Serono located in Bordeaux (France) from 1991 to 2003. From November 2003 to October 2006, Hervé Broly has been working as Program Director for the development of a recombinant protein for therapeutic use (atacicept) at Serono Corporate (Geneva, Switzerland) and then from November 2006 as Vice-President, Head of Biotech Process Sciences and Center of Expertise Biotech Bulk Manufacturing for Merck-Serono (Vevey, Switzerland). Current research focus relates to the improvement of the Merck Serono technology platform for the manufacture of McAbs and Fc-fusion recombinant proteins, to applying Quality by Design approach for the manufacture of bulk drug substance, and to the development of novel approaches for downstream processing.